Next-generation ovarian cancer therapy: Engineered Vδ2 T cells show promise in preclinical trials Post author: Post published:November 13, 2023 Post category:uncategorized A prospective path for allogeneic cellular immunotherapies. You Might Also Like Nicotine pouches pose growing danger to young children July 14, 2025 New guidelines aim to improve diagnosis and treatment of mycoplasma pneumoniae in children April 7, 2025 WHO publishes report introducing updated terminology for airborne pathogens April 22, 2024
New guidelines aim to improve diagnosis and treatment of mycoplasma pneumoniae in children April 7, 2025